Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD4-positive, alpha-beta T cell | 4 studies | 19% ± 3% | |
| astrocyte | 4 studies | 26% ± 7% | |
| glutamatergic neuron | 4 studies | 43% ± 16% | |
| oligodendrocyte | 4 studies | 22% ± 4% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| GABAergic neuron | 3 studies | 41% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 39% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 1815.79 | 578 / 578 | 100% | 4.40 | 1153 / 1155 |
| prostate | 100% | 1873.54 | 245 / 245 | 100% | 3.73 | 501 / 502 |
| breast | 100% | 1439.45 | 459 / 459 | 100% | 4.61 | 1115 / 1118 |
| brain | 100% | 1228.14 | 2632 / 2642 | 100% | 5.24 | 705 / 705 |
| uterus | 100% | 2039.08 | 170 / 170 | 100% | 3.73 | 457 / 459 |
| thymus | 100% | 2257.33 | 653 / 653 | 100% | 5.48 | 602 / 605 |
| esophagus | 100% | 1282.82 | 1442 / 1445 | 99% | 5.17 | 182 / 183 |
| intestine | 100% | 1681.32 | 966 / 966 | 99% | 3.28 | 522 / 527 |
| bladder | 100% | 1781.52 | 21 / 21 | 99% | 3.48 | 499 / 504 |
| kidney | 100% | 1166.92 | 89 / 89 | 98% | 4.32 | 887 / 901 |
| ovary | 100% | 2001.38 | 180 / 180 | 98% | 3.33 | 420 / 430 |
| stomach | 100% | 1027.42 | 359 / 359 | 98% | 3.63 | 279 / 286 |
| pancreas | 100% | 1020.99 | 327 / 328 | 97% | 3.77 | 173 / 178 |
| adrenal gland | 100% | 1238.93 | 258 / 258 | 96% | 4.46 | 220 / 230 |
| skin | 100% | 1524.52 | 1808 / 1809 | 93% | 3.24 | 441 / 472 |
| liver | 100% | 1095.65 | 226 / 226 | 85% | 1.97 | 345 / 406 |
| adipose | 100% | 1421.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.47 | 29 / 29 |
| spleen | 100% | 2404.73 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 3.29 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.63 | 1 / 1 |
| blood vessel | 100% | 1549.12 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 939.60 | 796 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 1147.46 | 836 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 79% | 1517.37 | 733 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 66% | 1.77 | 53 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0002682 | Biological process | regulation of immune system process |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0001817 | Biological process | regulation of cytokine production |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZBTB25 |
| Protein name | Zinc finger and BTB domain-containing protein 25 (Zinc finger protein 46) (Zinc finger protein KUP) Zinc finger and BTB domain containing 25 |
| Synonyms | KUP C14orf51 hCG_41676 ZNF46 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000555220.5 P24278 ENST00000555424.1 G3V351 ENST00000394715.1 ENST00000608382.6 G3V2K3 |
